Organization
Monument Therapeutics
1 clinical trial
Clinical trial
A Two-part, Single Dose, Randomized, Single Blinded, Placebo Controlled, Phase I Study to Assess the Safety and Pharmacokinetics of Oral MT1980 in Healthy Volunteers When Dosed in the Fasted StateStatus: Completed, Estimated PCD: 2022-10-04